Incyte Corporation (INCY): Price and Financial Metrics


Incyte Corporation (INCY): $75.89

0.26 (+0.34%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add INCY to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

INCY POWR Grades


  • INCY scores best on the Value dimension, with a Value rank ahead of 94.84% of US stocks.
  • INCY's strongest trending metric is Quality; it's been moving down over the last 179 days.
  • INCY ranks lowest in Momentum; there it ranks in the 12th percentile.

INCY Stock Summary

  • Incyte Corp's market capitalization of $17,641,830,815 is ahead of 86.49% of US-listed equities.
  • The ratio of debt to operating expenses for Incyte Corp is higher than it is for about merely 6.21% of US stocks.
  • Over the past twelve months, INCY has reported earnings growth of -348.8%, putting it ahead of merely 5.67% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Incyte Corp, a group of peers worth examining would be SGEN, WDC, QRVO, SIMO, and GSIT.
  • Visit INCY's SEC page to see the company's official filings. To visit the company's web site, go to www.incyte.com.

INCY Valuation Summary

  • INCY's price/earnings ratio is 50; this is 36.99% higher than that of the median Healthcare stock.
  • Over the past 243 months, INCY's price/earnings ratio has gone up 80.3.
  • Over the past 243 months, INCY's EV/EBIT ratio has gone up 86.9.

Below are key valuation metrics over time for INCY.

Stock Date P/S P/B P/E EV/EBIT
INCY 2021-08-31 6.2 5.8 50.0 37.1
INCY 2021-08-30 6.2 5.7 49.7 36.9
INCY 2021-08-27 6.1 5.7 49.5 36.7
INCY 2021-08-26 6.1 5.7 49.2 36.4
INCY 2021-08-25 6.1 5.7 49.6 36.7
INCY 2021-08-24 6.1 5.7 49.4 36.6

INCY Growth Metrics

    Its 3 year net cashflow from operations growth rate is now at 149.69%.
  • The 5 year net income to common stockholders growth rate now stands at -868.46%.
  • The year over year net cashflow from operations growth rate now stands at 695.62%.
INCY's revenue has moved up $2,128,327,000 over the prior 70 months.

The table below shows INCY's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 2,986.267 749.488 948.581
2021-09-30 2,912.923 741.458 534.58
2021-06-30 2,720.579 668.475 337.638
2021-03-31 2,702.913 764.913 478.48
2020-12-31 2,666.702 -124.599 -295.697
2020-09-30 2,456.582 -100.302 -334.542

INCY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • INCY has a Quality Grade of A, ranking ahead of 95.94% of graded US stocks.
  • INCY's asset turnover comes in at 0.76 -- ranking 198th of 563 Business Services stocks.
  • TSSI, APDN, and NUAN are the stocks whose asset turnover ratios are most correlated with INCY.

The table below shows INCY's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.760 0.951 0.546
2021-06-30 0.754 0.949 0.381
2021-03-31 0.787 0.951 0.523
2020-12-31 0.831 0.951 -0.231
2020-09-30 0.774 0.948 -0.298
2020-06-30 0.758 0.949 -0.138

INCY Price Target

For more insight on analysts targets of INCY, see our INCY price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $102.47 Average Broker Recommendation 1.56 (Moderate Buy)

INCY Stock Price Chart Interactive Chart >

Price chart for INCY

INCY Price/Volume Stats

Current price $75.89 52-week high $84.99
Prev. close $75.63 52-week low $61.91
Day low $75.21 Volume 711,200
Day high $76.14 Avg. volume 1,593,662
50-day MA $74.76 Dividend yield N/A
200-day MA $71.94 Market Cap 16.81B

Incyte Corporation (INCY) Company Bio


Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics in oncology in the United States and internationally. The company was founded in 1991 and is based in Wilmington, Delaware.


INCY Latest News Stream


Event/Time News Detail
Loading, please wait...

INCY Latest Social Stream


Loading social stream, please wait...

View Full INCY Social Stream

Latest INCY News From Around the Web

Below are the latest news stories about Incyte Corp that investors may wish to consider to help them evaluate INCY as an investment opportunity.

Insiders Buying Incyte And 2 More Stocks

Although U.S. stock futures traded higher this morning after recording losses on Tuesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company''s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga''s insider transactions platform. Incyte The Trade: Full story available on Benzinga.com

Benzinga | February 23, 2022

US Ecology, Incyte, and Other Stocks See Action From Activist Investors

Magnetar Capital disclosed a large stake in waste-management firm US Ecology. Baker Bros. increased the investment in biopharmaceutical firm Incyte.

Yahoo | February 19, 2022

7 Insider Stocks to Buy as Execs Snap Them Up

With equity prices soaring to record levels, many execs have cashed out.

Josh Enomoto on InvestorPlace | February 18, 2022

Incyte to Present at Upcoming Investor Conference

WILMINGTON, Del., February 15, 2022--Incyte to Present at Upcoming Investor Conference

Yahoo | February 15, 2022

4 Stocks That Wall Street Hates This Week

Here is another look at Exelon, Incyte and other stocks that Wall Street analysts expected little from in this past week.

24/7 Wall street | February 11, 2022

Read More 'INCY' Stories Here

INCY Price Returns

1-mo 0.00%
3-mo -5.07%
6-mo 3.39%
1-year -9.79%
3-year -11.16%
5-year -39.73%
YTD 3.39%
2021 -15.61%
2020 -0.39%
2019 37.32%
2018 -32.86%
2017 -5.55%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6319 seconds.